Clinical Trial Update: Panobinostat or Placebo With Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating panobinostat or placebo with bortezomib and dexamethasone in relapsed multiple myeloma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)
• DEXAMETHASONE (Dexamethasone)
• Panobinostat (Panobinostat)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED | Results posted: 2015-10-23